Procurement Summary
Country : Brazil
Summary : Registration of Drug Prices for Maintenance of the Basic Pharmacy of the Health Units of the Municipality.
Deadline : 21 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 122406647
Document Ref. No. : 90070/2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Price Registration of Medicines for Maintenance of the Basic Pharmacy of the Health Units of the Municipality.
UASG Code: 985499
Notice from: 09/07/2025 from 08:00 to 17:00
Proposal Delivery: From 07/09/2025 to 08:00
Folic acid, dosage 0.2 mg/ml, Use Oral Solution- Drops
Quantity: 800
Adenosine, dosage 3 mg/ml, indication injectable solution
Quantity: 30
Amissulprida, concentration 50 mg
Quantity: 2000
Amoxicillin, active ingredient associated with sulbactam, concentration 50mg + 50mgml, presentation powder for oral suspension
Amount : 600
Amoxicillin, active ingredient associated with potassium clavulanate, 80 mg + 11.5 mg/ ml, pharmaceutical form for oral suspension
Quantity: 100
Ampicillin, concentration 50 mg/ml, pharmaceutical form oral suspension
Quantity: 50
Atropine sulfate, dosage 0.50 mg/ml, use solution Injectable
Quantity: 100
Sodium bicarbonate, dosage 8.4%, use injectable solution
Quantity: 50
Budesonide, nasal aerosol presentation, concentration 64mcg/dose, additional characteristics with dosifying valve vial
Quantity: 1000
Activated charcoal, powdered pharmaceutical form
Amount : 200
Betamethasone, composition Dipropionate, associated with ketoconazole and neomicin A, concentration 0.5 mg/g + 20 mg/g + 1.5 mg/g, pharmaceutical cream
Quantity: 1500
Potassium chloride, dosage 19.1%, presentation injectable solution
Quantity: 50
Potassium chloride, 20%dosage, presentation Injectable solution
Quantity: 100
Cholestyramine, 4G dosage, presentation powder
Quantity: 1800
Dexamethasone, disorder phosphate presentation + neomicin_sulfate, concentration0.1% + 0.35%, use ophthalmic solution
Quantity: 1000
Dexlansoprazole, 30 mg concentration, additional characteristics release Prolonged
Quantity: 2000
Diltiazem hydrochloride, dosage 60 mg ...
Documents
Tender Notice